(Q40463923)

English

The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.

scientific article published on January 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

0 references

quality of life

1 reference

based on heuristic

inferred from title

myeloproliferative disorders

1 reference

based on heuristic

inferred from title

Srdan Verstovsek

4

object named as

Srdan Verstovsek

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

10

object named as

Ayalew Tefferi

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Pamela J Atherton

8

object named as

Pamela J Atherton

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Martha Wadleigh

3

object named as

Martha Wadleigh

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Ruben A Mesa

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Joyce Niblack

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

John Camoriano

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sunni Barnes

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Angelina D Tan

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jeff A Sloan

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

109

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

68-76

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis in transplant-eligible patients with agnogenic myeloid metaplasia: a simple CBC-based scoring system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of low-dose aspirin in polycythemia vera

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptoms, symptom distress and health-related quality of life in patients with polycythaemia vera or essential thrombocythaemia during treatment with interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of fatigue on physical activity and function in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment and management of cancer-related fatigue in adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory biomarkers for persistent fatigue in breast cancer survivors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Review of exercise intervention studies in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life changes following peripheral blood stem cell transplantation and participation in a mixed-type, moderate-intensity, exercise program.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22365

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22365

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40463923&oldid=2265552703"